The regulation compiles requirements for medical manufacturing, importation, exportation, storage, distribution, and commercialization of medical devices. 

Taiwan presents opportunities for U.S. dietary supplements due to growing sales.

Singapore’s plan is a holistic approach for lowering and tracking chronic kidney disease.

Wuhan, a city of over 10 million people, offers a $3.5 billion senior care market with a focus on innovative products related to in-home senior care.

The medical device sector is a great opportunity for U.S. companies looking to grow their exports in the region.

Denmark’s First Quantum Computer is expected to be fully functional in 2034, presenting a huge opportunity for businesses within the life science sectors. 

With one of the world’s best quality health data registries, Denmark is getting big on precision medicine – with support from the public and private sectors.

Documentation and registrations are required for submitting to the Hong Kong Hospital Authority’s tenders for vitamins. 

Hong Kong’s public medical service requires companies submitting tenders for vitamins to provide similar documentation as tenders for drugs. 

China’s Government supports development of healthcare services in the Greater Bay Area, consisting of 11 designated cities in South China, Hong Kong and Macau. 

Leading distributors of medical devices and pharmaceutical products in Hong Kong want to connect with U.S. suppliers. 

The Hong Kong Government allocates USD65 million to provide 15,000 additional hospital beds and 90+ operating theatres to meet projected service demand. 

U.S. health supplement contract manufacturers can find opportunities with private labels in Hong Kong.

Poland signed an agreement with the National Comprehensive Cancer Network of American oncology centers on cancer treatment, research & education.